Nivolumab is a PD-1 blocking monoclonal antibody used to treat melanoma, non-small cell lung cancer, kidney cancer, Hodgkin's lymphoma, head and neck cancer, urothelial and esophageal cancers. It works by blocking the PD-1 protein on immune cells, helping the immune system recognize and attack cancer cells more effectively.
Contraindicated in patients with severe hypersensitivity to nivolumab. Use cautiously in patients with autoimmune disorders, as it may exacerbate these conditions. May cause immune-related side effects including pneumonitis, colitis, hepatitis, and endocrine disorders. Not recommended during pregnancy. Schedule H prescription drug — administered only under medical supervision.
Manufactured under WHO-GMP and EU-GMP standards. Each batch undergoes rigorous quality testing for purity and potency before release for export.
COA, WHO-GMP certificates, Free Sale Certificate, MSDS, and Patient Information Leaflet provided with every export shipment. In stock for bulk/export orders.
Exported via GDP-compliant cold chain (2–8°C) logistics to LATAM, Africa, GCC, Middle East, and Southeast Asian markets. Air and sea freight available with full shipment tracking.
Supports named-patient supply, hospital procurement, and NGO/distributor partnerships in markets where Nivolumab is not yet locally registered.
What is Nivolumab used for?
Treats melanoma, lung cancer, kidney cancer and other advanced cancers by helping the immune system attack tumor cells.
What is the price of Nivolumab injection?
Available on request — send strength, quantity, and destination for a verified export quote.
Who is a reliable Nivolumab manufacturer in India?
We supply WHO-GMP certified Nivolumab with full documentation and GDP-compliant global logistics.
What is the usual dosage?
Dosage is individualized by the treating oncologist based on body weight and cancer type.
Are there side effects?
Immune-related reactions are possible; patients are monitored closely during treatment.
